** Medical device maker Nevro Corp's shares NVRO.N rise
14.1% to $5.73, while Globus Medical GMED.N shares fall 4.5%
to $88.22
** Globus Medical to acquire all shares of Nevro in an
all-cash transaction, representing a total equity value of ~$250
million
** Deal offers $5.85 per share for each share of Nevro Corp,
a premium of 16.5% to NVRO's last close
** Deal is expected to close late in Q2 2025
** In the last 12 months, GMED up 58.88%, while NVRO has
fallen 60.78%
(Reporting by Siddhi Mahatole)
((siddhiprabhanjan.mahatole@thomsonreuters.com))